Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IBS-C
IBS-C
Ironwood, AbbVie add 'bloating' and 'discomfort' to Linzess label to reach more IBS-C patients
Fierce Pharma
Fri, 10/9/20 - 10:55 am
Ironwood
AbbVie
Linzess
IBS-C
FDA
Ardelyx bags its first FDA OK for IBS, setting up a showdown with Allergan, Ironwood
Endpoints
Sun, 09/15/19 - 09:45 pm
Ardelyx
Ibsrela
tenapanor
IBS-C
FDA
Ardelyx eyes first drug approval after decade-long journey
Bizjournals
Thu, 09/12/19 - 10:20 am
Ardelyx
tenapanor
IBS-C
FDA
Ironwood, Allergan adds a slate of PhIIIb data to its Linzess pitch for physicians, patients
Endpoints
Wed, 06/19/19 - 09:49 am
Ironwood Pharmaceuticals
Allergan
Linzess
clinical trials
IBS-C
Synthetic Biologics Announces Trial with Cedars-Sinai to Study SYN-010 for the Treatment of IBS-C
CP Wire
Thu, 09/6/18 - 07:38 pm
Synthetic Biologics
IBS-C
SYN-010
Synthetic Biologics Announces Trial with Cedars-Sinai to Study SYN-010 for the Treatment of IBS-C
Thu, 09/6/18 - 12:16 pm
Synthetic Biologics
IBS-C
SYN-010
Ironwood Initiates Ph III Study of Linaclotide in IBS-C
CP Wire
Mon, 07/16/18 - 09:08 am
Ironwood Pharmaceuticals
Allergan
linaclotide
Linzess
IBS-C
Ironwood Initiates Ph III Study of Linaclotide in IBS-C
Mon, 07/16/18 - 09:06 am
Ironwood Pharmaceuticals
Allergan
linaclotide
Linzess
IBS-C
Allergan: Is Linzess 'Restasis 2.0'?
NY Shock Exchange
Mon, 10/23/17 - 09:42 am
Allergan
Restasis
patents
Linzess
Ironwood Pharmaceuticals
Teva Pharmaceutical
IBS-C
Synergy Pharmaceuticals Sinks on FDA Update
24/7 Wall St
Sat, 07/16/16 - 12:39 pm
Synergy Pharmaceuticals
FDA
chronic idiopathic constipation
IBS-C
plecanatide
Ironwood marks rare milestone: 1 million patients have taken Linzess
Bizjournals.com
Thu, 02/18/16 - 05:53 pm
Ironwood Pharmaceuticals
Linzess
IBS-C
Does Synergy Pharma's Plecanatide Blow Away The Competition?
Seeking Alpha
Fri, 07/17/15 - 10:08 am
Synergy Pharmaceuticals
IBS-C
plecanatide
Linzess
Ironwood
AstraZeneca, Ironwood to seek Chinese approval for linaclotide following positive results in late-stage IBS-C trial
First Word Pharma
Wed, 07/8/15 - 09:53 am
AstraZeneca
Ironwood
China
linaclotide
IBS-C
Next DTC push for Linzess: Spotlight patients, with big salesforce backup
Fierce Pharma Marketing
Thu, 04/9/15 - 10:02 am
Actavis
Ironwood
DTC
Linzess
IBS-C
Synergy Pharmaceuticals' plecanatide shows positive results in Phase 2B study
Yahoo/Fly on the Wall
Wed, 04/30/14 - 12:58 pm
Synergy Pharmaceuticals
plecanatide
IBS-C
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
Seeking Alpha
Fri, 02/21/14 - 11:19 am
Synergy Pharmaceuticals
IBS-C
Ironwood Pharmaceuticals
Linzess
Sucampo
plecanatide
Synergy Pharma Progresses with Plecanatide
Yahoo/Zacks.com
Fri, 12/27/13 - 09:40 am
Synergy Pharmaceuticals
plecanatide
IBS-C
Ironwood Implies Upside For Synergy; Lessons Learned From Dendreon
Seeking Alpha
Thu, 10/25/12 - 11:03 am
Ironwood
Dendreon
Synergy Pharmaceuticals
Forest Labs
Novartis
IBS-C
linaclotide
Sucampo presents data for AMITIZA for treatment of IBS-C
Yahoo/Fly on the Wall
Mon, 05/21/12 - 12:52 pm
Sucampo
Amitiza
IBS
IBS-C